This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
resources:ohdsi_symposium_2017_poster_submissions [2017/08/31 17:21] patrick_ryan [Submissions:] |
resources:ohdsi_symposium_2017_poster_submissions [2017/09/08 19:45] patrick_ryan [Submissions:] |
||
---|---|---|---|
Line 87: | Line 87: | ||
* Choi, Myung - {{:resources:omoponfhir_for_data_analytics.pdf|OMOP on FHIR for Data Analytic Application Platform}} | * Choi, Myung - {{:resources:omoponfhir_for_data_analytics.pdf|OMOP on FHIR for Data Analytic Application Platform}} | ||
* Evans, Lee {{:symposium_2017:LTS_OHDSI_submission.pdf|Broadsea API - OHDSI methods as a cloud service}} | * Evans, Lee {{:symposium_2017:LTS_OHDSI_submission.pdf|Broadsea API - OHDSI methods as a cloud service}} | ||
- | * Abdul-Basser, Taha {{:symposium_2017:ohdsi-2017-abstract-k_natarajan.docx|A Demonstration of Several Analytic Uses Cases with OHDSI Components Deployed on Google Cloud}} | + | * Abdul-Basser, Taha {{:symposium_2017:ohdsi-2017-abstract-k_natarajan.pdf|A Demonstration of Several Analytic Uses Cases with OHDSI Components Deployed on Google Cloud}} |
* Feeney, Kristin {{:symposium_2017:deeplearning_feeneyrobert-etal.pdf|Building Deep Learning Models with the OMOP CDM}} | * Feeney, Kristin {{:symposium_2017:deeplearning_feeneyrobert-etal.pdf|Building Deep Learning Models with the OMOP CDM}} | ||
* Feeney, Kristin {{:symposium_2017:networkanalysis_feeney.pdf|Network Analysis of OHDSI Collaboration}} | * Feeney, Kristin {{:symposium_2017:networkanalysis_feeney.pdf|Network Analysis of OHDSI Collaboration}} | ||
* Pratt, Nicole {{:symposium_2017:ohdsi_symposium_abstract_feasibility.pdf|The feasibility of utilising the OHDSI network to generate large-scale evidence of the safety of biologics}} | * Pratt, Nicole {{:symposium_2017:ohdsi_symposium_abstract_feasibility.pdf|The feasibility of utilising the OHDSI network to generate large-scale evidence of the safety of biologics}} | ||
* Pratt, Nicole {{:symposium_2017:ohdsi_symposium_abstract_biologicsstudy.pdf|Utilising the power of the OHDSI network to generate large scale evidence of the safety of biologics}} | * Pratt, Nicole {{:symposium_2017:ohdsi_symposium_abstract_biologicsstudy.pdf|Utilising the power of the OHDSI network to generate large scale evidence of the safety of biologics}} | ||
- | * Van Speybroeck, Michel {{:resources:ohdsi-poster_emif_pr.pdf|Assessment of the conversion of ten European Databases to the OMOP CDM mapping and evaluation of the use of OHDSI tools in that process}} | + | * Dymshyts, Dmitry {{:symposium_2017:abstractdymshytssymposium2017.pdf|Variability of Drug Attributes in the US Market (RxNorm) compared to selection of Worldwide Market (RxNorm Extension)}} |
+ | * Klebanov, Gregory {{:resources:arachne_abstract_symposium_2017_-_1.pdf|ARACHNE – Distributed OHDSI Research Network and Study Workflow Orchestration}} | ||
+ | * Busby, Ben {{:resources:ohdsi_pubrunner_abstract.pdf|PubRunner: A framework to update biomedical text mining analysis with the latest publications}} | ||
+ | * Jiang, Guoqian {{:resources:poster-fhirontopohdsi-v1.0.pdf|FHIROntopOHDSI: A Semantic Web-based Data Access Framework with the OHDSI Data Repositories Using FHIR}} | ||
+ | * Galaznik, Aaron {{:symposium_2017:abstractgalazniksymposium2017_v2.docx|}}: Predictive Modeling as an OHDSI Network Study: Treatment Non-Response in NSCLC patients treated with ALK Inhibitors | ||
+ | * Yuan,Chi {{:resources:ohdsi_poster_time_generalizability_yuan_5sept2016.pdf|Generalizability of randomized trial follow-up time to real-world practice}} | ||
+ | |||
+ | ***SUBMISSIONS CLOSED*** |